Evidence map›Paper›PMID 38877766›Full record

ReviewJournal of the European Academy of Dermatology and Venereology : JEADV2025

International expert consensus recommendations for the use of dermocosmetics in acne.

Diane Thiboutot, Alison M Layton, Ibrahima Traore, Gabriel Gontijo, Patricia Troielli, Qiang Ju, Ichiro Kurokawa, Brigitte Dreno

Abstract readConsensus StatementReview
In one paragraph

Review in Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Observational
  7. Review
  8. Review
  9. Review
  10. Article
  11. The Role of Dermocosmetics in Acne Management: Asian Perspective.Clinical, cosmetic and investigational dermatology · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. International expert consensus recommendations for the use of dermocosmetics in acne.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Diane ThiboutotMilton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Alison M LaytonSkin Research Centre, Hull York Medical School, University of York, York, UK.
Ibrahima TraoreDermatology Clinic, Conakry Region, Guinea.ORCID https://orcid.org/0000-0002-6669-3802
Gabriel GontijoDermatology Clinic, Belo Horizonte, Minas Gerais, Brazil.
Patricia TroielliDepartment of Dermatology, University of Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-3070-3917
Qiang JuDepartment of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Ichiro KurokawaDepartment of Dermatology, Meiwa Hospital, Meiwa, Japan.
Brigitte DrenoNantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.ORCID https://orcid.org/0000-0001-5574-5825

Funding

La Roche-Posay LaboratoireL'Oreal Dermatological Beauty
6 · The paper itself

Abstract

backgroundA wide variety of dermocosmetics (products with both active skincare and cosmetic activity) are available for the management of acne vulgaris. These products are important because they may be the first line of approach for patients desiring to self-treat and they can also have beneficial effects-reducing lesion counts and improving global acne severity. When used in conjunction with medical therapy, dermocosmetics can improve tolerability and enhance results. We reviewed available evidence and combined it with our clinical experience to help guide clinicians in selecting skincare products with acne-targeting ingredients.

methodsAn international panel of dermatologists with an interest and expertise in managing acne performed a literature review, formulated clinical questions related to the role of dermocosmetics in the acne setting, used a modified GRADE approach to evaluate available evidence and then utilized an online iterative Delphi process to create consensus recommendations. It should be noted that due to the limited number of available studies, the category of dermocosmetics was evaluated rather than specific ingredients.

resultsThe quality of evidence was found to be low to moderate. Key recommendations were made based on available evidence for the use of dermocosmetics in acne to improve acne global assessment, reduce acne lesion counts, reduce superficial skin oiliness and serve as maintenance therapy after medical treatment, while providing a good tolerability. Recommendations were also made for using dermocosmetics as adjuncts to medical treatment.

conclusionsWhile there is a need for better quality evidence, dermocosmetics have demonstrated some benefit for acne both when used alone in its milder clinical presentations or in maintenance post acne medication and as adjunct to acne treatments.

Indexed as

Acne VulgarisCosmeticsDermatologic AgentsSkin CareConsensusHumansCosmeticsDermatologic Agents

Identifiers

PMID38877766
PMCPMC12023719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.